Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017039 · ClinicalTrials.gov registry record · NA
Sleep, Blood Pressure and Vascular Health
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT04017039 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 107 participants.
The verdict
NCT04017039, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
The investigators hypothesize that chronic insufficient sleep is associated with diminished endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Furthermore, the investigators hypothesize that the postulated diminishment in endothelial vasodilator and fibrinolytic function with insufficient sleep will be due, at least in part, to increased oxidative stress. Furthermore, increasing sleep duration and improving sleep quality will increase both endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Increases in endothelial vasodilator and fibrinolytic function will be due, at least in part, to reduced oxidative stress.
Interventions
- OTHER Targeted Sleep Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2016-11-10 |
| Est. Completion | 2023-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04017039
The ClinicalTrials.gov registry entry for NCT04017039 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Targeted Sleep Intervention is the first listed.
NCT04017039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04017039 about?
NCT04017039 is a clinical study titled "Sleep, Blood Pressure and Vascular Health". The investigators hypothesize that chronic insufficient sleep is associated with diminished endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Furthermore, the investigators hypothesize that the p...
What is the current status of trial NCT04017039?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2016-11-10. Estimated completion is 2023-05.
What interventions are being tested in trial NCT04017039?
The interventions under investigation include: Targeted Sleep Intervention (OTHER).
Who is sponsoring clinical trial NCT04017039?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.